PLT Health Solutions has received permission from Health Canada to make specific joint and cartilage health claims for its functional ingredient, AprèsFlex.
The nutraceutical ingredients provider can now make a range of specialised and general health claims for the botanical extract in the marketing process, including:
- Long-term joint health benefits/support/pain relief for those with mild to moderate osteoarthritis of the knee
- Helps to promote joint comfort and combat stiffness
- Helps to maintain cartilage (thickness and volume)
- Assists in improving mobility and joint functionality
The claim approvals from Health Canada stem from the four human clinical trials which assessed the benefits of AprèsFlex, which found the ingredient to be useful for those suffering with mild to moderate osteoarthritis of the knee.
The Boswellia serrata gum resin extract can be used as a standalone ingredient or in combination with other joint health-promoting nutraceuticals.
CEO and President of PLT Health Solutions, Seth Flowerman, commented: "With four gold-standard human clinical trials and counting, we are proud that AprèsFlex is one of the best substantiated joint health ingredients on the market today, powering some of the leading joint health consumer brands around the world,"
"The combination of fast acting experiential improvements in joint comfort with demonstrated long-term efficacy, and now with the newly demonstrated claims on cartilage health – both preservation and protection – offers the industry never-before available messaging opportunities for consumer products benefiting people of all ages - and all in a single, low daily dose of 100mg.”
